Thu, Apr 17, 2014, 3:28 AM EDT - U.S. Markets open in 6 hrs 2 mins

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • traderguystocks traderguystocks Nov 21, 2012 11:52 AM Flag

    Piper Jaffary "NEAR TERM for SRPT $60-$80 AFTER APPROVAL $160" link

    Piper Jaffary "NEAR TERM for SRPT $60-$80 AFTER APPROVAL $160 " **link**
    Street Insider
    Sarepta Therapeutics (SRPT) Jumps on Bullish CommentS
    November 21, 2012 9:18 AM EST
    Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is seeing strong pre-open action following positive comments from analysts at Piper Jaffray. The firm said it has the potential to be a $160/share stock but a nearer-term range could be $60-$80/share.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Based on the size of the market, especially with the ANCHOR indication in hand, if AMRN GIA, it will be a $100+++ stock.
      SRPT has a great and much needed product that's going to be approved soon, but the market is not even close to the size of the market Vascepa will be competing in.

      Sentiment: Strong Buy

 
AMRN
1.60+0.07(+4.58%)Apr 16 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Google Inc.
NasdaqGSWed, Apr 16, 2014 4:00 PM EDT
Google Inc.
NasdaqGSWed, Apr 16, 2014 4:00 PM EDT